Patent · US Active

Method for detecting neoplastic disorders in a solubilized body sample

US7932047B2 · kind B2 · utility

3Cited by

26References

35Claims

0Family size

Assignee

MTM Laboratories, AG · DE

Inventors

Ruediger Ridder · Schriesheim, DE
Anja Reichert · Schallstadt, DE
Magnus Von Knebel Doeberitz · Heidelberg, DE
Matthias Herkert · Heidelberg, DE
Alexander Duwe · Heidelberg, DE
Rainer Hipfel · Wiesbaden, DE
Peter Martin · Far Hills, US

Key dates

Filing date	Aug 20, 2004
Grant date	Apr 26, 2011
Priority date	—
Expiry date	Nov 25, 2027

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/25
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to a method for the early diagnosis of neoplastic disorders such as cancers as well as their precursor stages, particularly cancers of the respiratory tract, the urinary system, the reproductive tract, cancer associated with HPV infection or cancer of the anogenital tract, from solubilized body samples. The invention is also directed to test kits usable for this purpose as well as in-vitro diagnostic devices. The development of the kits and in-vitro diagnostic devices for the above purpose is also one aspect of the present invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.